focus -WSS

focus

author：hotspot 2025-09-06 04:30:38 - browse：82163

An exercise physiologist works with a patient at a cardiac rehab class — Medicare plans to pay more for a type of cardiac rehabilitation that takes place in certain outpatient clinics owned by hospitals, going against growing support for site-neutral payments. Photo illustration: STAT, Photo: Mark Duncan/AP

Medicare plans to pay more for a type of cardiac rehabilitation that takes place in certain outpatient clinics owned by hospitals.

Medicare has admitted it is doing so due to an error in reading federal law, but it also goes against the grain of the current environment, where support for site-neutral payments has never been higher. Some members of Congress and health care experts are pushing for a system that would not pay hospital outpatient departments more for identical services that are provided in lower-priced physician offices.

Naturally, hospitals cheered regulators for increasing payments. But they don’t want the government to stop there. They also want Medicare to retroactively reprocess all underpaid heart rehab sessions, and they are using this proposal as a way to reiterate their desire to kill all policies that would pay hospital-owned clinics the same as physician offices.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Test for long Covid? Researchers find new clue in blood samples

focus

WSS

Research misconduct: Proposed new rules face resistance

Test for long Covid? Researchers find new clue in blood samples

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Research misconduct: Proposed new rules face resistance

In 'major milestone,' FDA approves first cell therapy for solid tumors

Research misconduct: Proposed new rules face resistance

explore

focus

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare Advantage enrollment hits roughly 33.4 million

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare Advantage today, explained in one chart

BioMarin wins approval for gene therapy to treat hemophilia A

New study raises questions about niacin and heart health

Hepatitis C has a cure — but many Americans still lack access to it

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Apple is now the first public company to be valued at $3 trillion

Francis Collins on trust in science and how Covid communications failed

hotspot

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Medicare Advantage enrollment hits roughly 33.4 million

Ukraine seeks to reclaim its role as a hub for clinical trials

MD Anderson's Padmanee Sharma responds to research credit suit

Opioid cravings were reduced by anti

Research misconduct: Proposed new rules face resistance

leisure time

leisure time

focus

hotspot